Your browser doesn't support javascript.
loading
A New Risk Prediction Model for Venous Thromboembolism and Death in Ambulatory Lung Cancer Patients.
Gomez-Rosas, Patricia; Giaccherini, Cinzia; Russo, Laura; Verzeroli, Cristina; Gamba, Sara; Tartari, Carmen Julia; Bolognini, Silvia; Ticozzi, Chiara; Schieppati, Francesca; Barcella, Luca; Sarmiento, Roberta; Masci, Giovanna; Tondini, Carlo; Petrelli, Fausto; Giuliani, Francesco; D'Alessio, Andrea; Minelli, Mauro; De Braud, Filippo; Santoro, Armando; Labianca, Roberto; Gasparini, Giampietro; Marchetti, Marina; Falanga, Anna.
Affiliation
  • Gomez-Rosas P; Immunohematology and Transfusion Medicine, Hospital Papa Giovanni XXIII, 24127 Bergamo, Italy.
  • Giaccherini C; Cardiovascular Research Institute Maastricht (CARIM), Maastricht University Medical Center (MUMC+), 6229 ER Maastricht, The Netherlands.
  • Russo L; Hospital de Oncologia, Unidad Medica de Alta Especialidad (UMAE), Centro Medico Nacional Siglo XXI, Instituto Mexicano del Seguro Social (IMSS), Mexico City 06720, Mexico.
  • Verzeroli C; Immunohematology and Transfusion Medicine, Hospital Papa Giovanni XXIII, 24127 Bergamo, Italy.
  • Gamba S; Immunohematology and Transfusion Medicine, Hospital Papa Giovanni XXIII, 24127 Bergamo, Italy.
  • Tartari CJ; Immunohematology and Transfusion Medicine, Hospital Papa Giovanni XXIII, 24127 Bergamo, Italy.
  • Bolognini S; Immunohematology and Transfusion Medicine, Hospital Papa Giovanni XXIII, 24127 Bergamo, Italy.
  • Ticozzi C; Immunohematology and Transfusion Medicine, Hospital Papa Giovanni XXIII, 24127 Bergamo, Italy.
  • Schieppati F; Immunohematology and Transfusion Medicine, Hospital Papa Giovanni XXIII, 24127 Bergamo, Italy.
  • Barcella L; Immunohematology and Transfusion Medicine, Hospital Papa Giovanni XXIII, 24127 Bergamo, Italy.
  • Sarmiento R; Immunohematology and Transfusion Medicine, Hospital Papa Giovanni XXIII, 24127 Bergamo, Italy.
  • Masci G; Immunohematology and Transfusion Medicine, Hospital Papa Giovanni XXIII, 24127 Bergamo, Italy.
  • Tondini C; Oncology Unit, Hospital San Filippo Neri, 00135 Rome, Italy.
  • Petrelli F; Oncology Unit, IRCCS Humanitas Institute, 20089 Rozzano, Italy.
  • Giuliani F; Oncology Unit, ASST Papa Giovanni XXIII, 24127 Bergamo, Italy.
  • D'Alessio A; Oncology Unit, Hospital Treviglio-Caravaggio, 24047 Treviglio, Italy.
  • Minelli M; Oncology Unit, IRCCS Cancer Institute Giovanni Paolo II, 70124 Bari, Italy.
  • De Braud F; Medical Oncology and Internal Medicine, Policlinico San Marco, Gruppo San Donato Zingonia-Bergamo, 24046 Zingonia, Italy.
  • Santoro A; Oncology Unit, Hospital San Giovanni Addolorata, 00184 Rome, Italy.
  • Labianca R; Oncology Unit, IRCCS National Cancer Institute, 20133 Milan, Italy.
  • Gasparini G; Oncology Unit, IRCCS Humanitas Institute, 20089 Rozzano, Italy.
  • Marchetti M; Fondazione ARTET Onlus, 24121 Bergamo, Italy.
  • Falanga A; Oncology Unit, Hospital San Filippo Neri, 00135 Rome, Italy.
  • On Behalf Of The Hypercan Investigators; Immunohematology and Transfusion Medicine, Hospital Papa Giovanni XXIII, 24127 Bergamo, Italy.
Cancers (Basel) ; 15(18)2023 Sep 15.
Article in En | MEDLINE | ID: mdl-37760562
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Etiology_studies / Prognostic_studies / Risk_factors_studies Language: En Journal: Cancers (Basel) Year: 2023 Document type: Article Affiliation country: Italy Country of publication: Switzerland
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Etiology_studies / Prognostic_studies / Risk_factors_studies Language: En Journal: Cancers (Basel) Year: 2023 Document type: Article Affiliation country: Italy Country of publication: Switzerland